NN Conference is a world-class International event in Nanosciences and Nanotechnologies (N&N) that focuses on the latest advances on N&N and promotes profound scientific discussions between scientists, researchers from different disciplines and...
medication management, announced that Nnamdi Njoku has been appointed President of the Company, effective July 1, 2026. Mr. Njoku will retain his role of Chief Operating Officer (COO), while Randall Lipps will continue to serve as Chief Executive...
for all strengths of Wegovy® pill includes Novo Nordisk Inc. partner-reported paid claims only from January 5, 2026 through June 2, 2026. †Terms apply. For eligible Medicare patients prescribed Wegovy® for a covered FDA-approved indication....
standards. U.S. sales of Bortezomib for Injection were approximately $43 million for the twelve months ending in March 2026.¹ Indications Bortezomib for Injection is indicated for the treatment of adult patients with multiple myeloma and mantle...
made via fermentation. The expansion follows a period of rapid commercial growth for EVERY: in the first four months of 2026, the company secured annual orders worth 550% of its total 2025 order volume. This surge is driven by strong adoption...
These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 -...
The DIA 2026 Global Annual Meeting is evolving, just like the life sciences community it serves. Join global innovators, regulators, academics, patient advocates, and industry leaders for an all-new experience designed to inspire, engage, and...
AbbVie announced new Phase 3 data on a fixed-duration venetoclax-based combination. Final results from the Phase 3 CLL14 trial in previously untreated chronic lymphocytic leukemia (CLL), which was conducted in collaboration with the German CLL...
mean Hgb improvement of at least 1g/dL as early as Week 1.1,c To be presented at the European Hematology Association (EHA) 2026 Congress, these results mark an important step forward for people living with wAIHA, a rare, life-threatening condition...
in radiance and fine lines/wrinkles with visible reduction in pore size. About Beauty Crush Skincare Launched in 2026, Beauty Crush represents the culmination of over two decades of award-winning skincare innovation by Karen Behnke. Headquartered...
medical imaging continuing to grow, Brain Navi plans to begin a full-scale market push in Taiwan in the second-half of 2026 and will be working closely with medical institutions, distribution partners, and clinical professionals to accelerate the...
SK bioscience announced that it has been designated as a supplier of influenza vaccines for UNICEF's 2026 immunization programs and has begun shipments for countries in the Southern Hemisphere. Beginning in September, the company will also...
pharmacies and other approved healthcare distribution partners, starting in Germany, Austria, and Switzerland on June 1, 2026, with further roll-out across various countries planned over the next two years. About Ascensia Diabetes Care Ascensia...
days two through five.3 The approval occurred ahead of the Prescription Drug User Fee Act (PDUFA) action date of June 16, 2026. “The FDA approval of XOCOVA provides an important new approach to preventing COVID-19, which continues to impact lives....
AVD for previously untreated Stage III or IV cHL in adults and pediatric patients 12 years and older, granted in March 2026.2 Earlier this year, the EC also approved Opdivo in combination with brentuximab vedotin for the treatment of children 5...
plan to progress the current IIT and file an IND application in China to conduct a Phase 1 clinical trial later in 2026. Jason C. Foster, CEO, Ori Biotech, said: “This is the milestone we’ve been building toward for the last 7 years — IRO®...
The 9th Annual Digi-Tech Pharma & AI conference, a premier Pharmaceutical Technology Conference, brings with it even more interactive sessions, expert speakers, senior professionals and decision makers from leading pharma, bio-tech and healthcare...
benefit from extended endocrine therapy beyond five years.2,3 More information on these findings will be presented at the 2026 ASCO Annual Meeting on June 1. The data come from a new analysis of the ongoing BCI Registry Study, which evaluates how...
builds on Aspera’s inaugural ADAR1p150 crystallization experiment, which launched aboard SpaceX Crew-12 in February 2026. Funded through NASA’s In Space Production Applications (InSPA) Phase 2 award, the work uses Redwire Corporation’s...
included patients with carcinoma in situ (CIS), with or without papillary tumors (±Ta/T1). The findings – presented at the 2026 American Urological Association (AUA) Annual Meeting and scheduled for publication in Translational Andrology and...
